Arava Treatment, between Beneficial Action on Joint Inflammation and Side Effects on Liver, Myocardium and Kidney in Experimental Murine ArthritisReportar como inadecuado




Arava Treatment, between Beneficial Action on Joint Inflammation and Side Effects on Liver, Myocardium and Kidney in Experimental Murine Arthritis - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

The purpose of the experiment was the follow-up in time of the course of joint inflammation phenomena in laboratory animals white female adult Wistar rats by determining particular biological, hematological, radiological, osteodensitometric, immunological and anatomic-pathological parameters and by assessing the effects of Leflunomide Arava on the course of the disease. ARAVA® Leflunomide is a pyrimidine synthesis inhibitor. The experimental study was conducted for 8 weeks. We have also assessed the side effects of the therapy on their liver, myocardium and kidney. Leflunomide therapy improved the course of the clinical and paraclinical parameters, but it did not cure the condition. The positive results in the joints were accompanied by many histological alterations. The experiment revealed the toxic visceral effects of Leflunomide on the liver, heart and kidney.

KEYWORDS

ARAVA® Leflunomide, Rheumatoid Arthritis, Side Effects

Cite this paper

Manole, M. , Badescu, C. , Ciocoiu, M. , Badescu, M. and Chicu, M. 2014 Arava Treatment, between Beneficial Action on Joint Inflammation and Side Effects on Liver, Myocardium and Kidney in Experimental Murine Arthritis. Journal of Biomedical Science and Engineering, 7, 712-720. doi: 10.4236-jbise.2014.79070.





Autor: Mihaela Manole, Codruta Badescu, Manuela Ciocoiu, Magda Badescu, Mihaiela Chicu

Fuente: http://www.scirp.org/



DESCARGAR PDF




Documentos relacionados